Test Price
1,200 AED✅ Home Collection Available
Crimean-Congo Hemorrhagic Fever (CCHF) Virus RNA Detection (Qualitative) Test in UAE
Executive Summary & Core Metrics
- 99.9% Diagnostic Sensitivity – ISO‑accredited real‑time PCR with confirmatory whole‑genome sequencing available.
- Premium Logistics – Hospital‑grade cold‑chain home collection & VIP mobile phlebotomy (8 AM – 11 PM) for blood samples; CSF collection conducted strictly within hospital settings.
- Clinical Guidance – Post‑test telephonic interpretation by a DHA‑licensed General Practitioner included.
- Insurance Support – Direct billing verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Crimean‑Congo Hemorrhagic Fever (CCHF) virus RNA detection test is a molecular assay that identifies the genetic material of the virus in whole blood, serum, plasma, or cerebrospinal fluid (CSF), enabling early diagnosis before antibodies appear. This qualitative real‑time PCR is the gold standard for rapid confirmation, critical for timely isolation, contact tracing, and supportive management in the UAE’s infectious disease framework.
Technological Comparison
| Parameter | Our CCHF RNA qPCR Test | Traditional ELISA Serology |
|---|---|---|
| Detection Target | Viral RNA (direct pathogen detection) | IgM/IgG antibodies (host immune response) |
| Analytical Sensitivity | >99.9% (detects <10 copies/reaction) | ~85–95% (seroconversion‑dependent) |
| Window Period | 1–4 days post‑symptom onset | 5–14 days (may miss early infection) |
| Turnaround Time | Phone: 36 h | Email: 4 working days | 1–3 days after sample arrival |
| Confirmatory Testing | Whole‑genome sequencing optional | Requires paired sera & reference lab |
Physician Insight & Safety Protocols
“As a general practitioner, I understand the anxiety a suspected CCHF diagnosis brings. This PCR test delivers the fastest, most accurate detection, allowing us to initiate isolation and supportive care immediately. However, a negative result in the early febrile phase does not exclude infection; please follow up clinically and never alter prescribed medications without consulting your physician.”
— Dr. Ajay Singh, DHA Licensed General Practitioner (DHA Registration ID: 36234132)
Medication Safety Advisory
Do not discontinue any prescribed antiviral, anticoagulant, or supportive medication without explicit consultation with your treating doctor. Abrupt cessation may worsen the clinical course.
Exclusion Criteria & Emergency Red Flags
- Individuals with known severe bleeding disorders (e.g., platelet count <20,000/µL, haemophilia) must inform the phlebotomist prior to blood draw.
- CSF collection is performed only if clinically indicated and under specialist supervision in a hospital setting.
- Seek immediate emergency care if you develop sudden high fever, severe headache, muscle pain, nausea, vomiting, abdominal pain, or any bleeding signs such as petechiae, nosebleeds, gum bleeding, or blood in vomit/stool – these are red flags of hemorrhagic fever progression and require urgent hospitalisation.
Patient FAQ & Clinical Guidance
1. What is the purpose of the CCHF RNA detection test, and when should it be taken?
Key Answer: The test directly detects the genetic material of Crimean-Congo hemorrhagic fever virus in blood or cerebrospinal fluid, enabling earliest possible diagnosis when fever and non‑specific symptoms begin. Early detection is critical for isolation and supportive management.
2. How should I prepare, and what does home collection involve?
Key Answer: Sign the consent form and bring your clinical history. A certified phlebotomist arrives at your location with a temperature‑controlled transport box within the booked 8 AM–11 PM slot for blood samples, ensuring sample integrity for 36‑hour phone results. CSF collection is only performed in hospital under specialist supervision.
3. Are the results definitive, and what should I do if the result is negative but symptoms persist?
Key Answer: A positive result confirms active CCHF infection with near‑absolute certainty. However, a negative result in the first 3–4 days of illness may require repeat testing because viral RNA levels can be initially low. Clinical isolation and monitoring should continue until the diagnosis is ruled out.
UAE Regulatory & Data Privacy Adherence
This diagnostic service operates in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access-controlled, and processed exclusively within UAE jurisdiction. The laboratory holds DHA Facility License No. 1143 and adheres to the highest standards of clinical confidentiality and data security.
Clinical & Logistical Metadata
| Parameter | Value |
|---|---|
| Test Name | Crimean-Congo Hemorrhagic Fever (CCHF) Virus RNA Detection (Qualitative) Test |
| Price (AED) | 1200 AED |
| Turnaround Time | Phone: 36 hours / Email: 4 working days |
| Sample Type / Matrix | Whole blood, serum, plasma (home collection available); cerebrospinal fluid (CSF) – hospital extraction only |
| Methodology Used | Real‑time reverse transcriptase polymerase chain reaction (RT‑qPCR) with optional whole‑genome sequencing |
| ICD-10-CM Code | A98.0 |
| LOINC Code | 94461-6 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians